CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 447 filers reported holding CRISPR THERAPEUTICS AG in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,199,000 | -89.0% | 85,549 | -72.2% | 0.02% | -85.5% |
| Q4 2020 | $47,054,000 | +92.0% | 307,320 | +4.9% | 0.12% | +59.0% |
| Q3 2020 | $24,510,000 | +21.3% | 293,041 | +6.6% | 0.08% | +9.9% |
| Q2 2020 | $20,204,000 | +63.5% | 274,917 | -5.6% | 0.07% | +29.1% |
| Q1 2020 | $12,357,000 | -28.2% | 291,374 | +3.2% | 0.06% | -3.5% |
| Q4 2019 | $17,202,000 | +17.5% | 282,434 | -20.9% | 0.06% | +14.0% |
| Q3 2019 | $14,634,000 | +10.2% | 357,021 | +58.0% | 0.05% | +28.2% |
| Q2 2018 | $13,278,000 | +209.6% | 225,970 | +6.7% | 0.04% | +200.0% |
| Q4 2016 | $4,289,000 | – | 211,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |